Latest Insider Transactions at Catalyst Pharmaceuticals, Inc. (CPRX)
This section provides a real-time view of insider transactions for Catalyst Pharmaceuticals, Inc. (CPRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CATALYST PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CATALYST PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2023
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+50.0%
|
-
|
|
Dec 27
2023
|
Preethi Sundaram Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,409
-13.92%
|
-
|
|
Dec 27
2023
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,666
+27.81%
|
-
|
|
Dec 27
2023
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.21%
|
-
|
|
Dec 27
2023
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,623
-1.81%
|
-
|
|
Dec 27
2023
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,666
+4.4%
|
-
|
|
Dec 15
2023
|
Molly Harper Director |
SELL
Open market or private sale
|
Direct |
14,000
-100.0%
|
$196,000
$14.4 P/Share
|
|
Dec 15
2023
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$50,000
$5.78 P/Share
|
|
Dec 12
2023
|
David S Tierney Director |
SELL
Open market or private sale
|
Direct |
50,000
-13.04%
|
$650,000
$13.32 P/Share
|
|
Dec 12
2023
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+11.53%
|
$50,000
$1.13 P/Share
|
|
Dec 11
2023
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+15.83%
|
$150,000
$1.13 P/Share
|
|
Dec 11
2023
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
60,000
-32.19%
|
$780,000
$13.77 P/Share
|
|
Dec 11
2023
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+35.18%
|
$60,000
$1.13 P/Share
|
|
Dec 08
2023
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
40,000
-25.22%
|
$560,000
$14.28 P/Share
|
|
Dec 08
2023
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+30.64%
|
$40,000
$1.13 P/Share
|
|
Dec 07
2023
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+22.39%
|
$60,000
$1.13 P/Share
|
|
Dec 06
2023
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
50,000
-56.58%
|
$700,000
$14.02 P/Share
|
|
Dec 06
2023
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+36.14%
|
$50,000
$1.13 P/Share
|
|
Dec 05
2023
|
Steve Miller Chief Op. & Scientific Officer |
SELL
Open market or private sale
|
Direct |
40,000
-5.82%
|
$560,000
$14.24 P/Share
|
|
Aug 03
2023
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+13.25%
|
$60,000
$1.13 P/Share
|
|
Jun 27
2023
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,942
-22.47%
|
-
|
|
Jun 27
2023
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+36.31%
|
-
|
|
May 16
2023
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
173,849
+4.05%
|
$0
$0.79 P/Share
|
|
May 15
2023
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
26,151
-0.66%
|
$339,963
$13.23 P/Share
|
|
May 15
2023
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
26,151
+0.65%
|
$0
$0.79 P/Share
|
|
May 12
2023
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+25.25%
|
$0
$0.79 P/Share
|
|
May 11
2023
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+12.7%
|
$0
$0.79 P/Share
|
|
May 11
2023
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+5.66%
|
$0
$0.79 P/Share
|
|
May 04
2023
|
Philip H Coelho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+19.62%
|
$0
$0.79 P/Share
|
|
Apr 05
2023
|
David S Tierney Director |
SELL
Open market or private sale
|
Direct |
30,000
-8.73%
|
$480,000
$16.83 P/Share
|
|
Apr 05
2023
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+8.03%
|
$0
$0.79 P/Share
|
|
Mar 29
2023
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
50,000
-20.41%
|
$800,000
$16.7 P/Share
|
|
Mar 29
2023
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+33.21%
|
$50,000
$1.13 P/Share
|
|
Mar 29
2023
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
40,000
-72.58%
|
$640,000
$16.7 P/Share
|
|
Mar 29
2023
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+42.06%
|
$120,000
$3.23 P/Share
|
|
Mar 28
2023
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
58,216
-17.26%
|
$931,456
$16.51 P/Share
|
|
Mar 28
2023
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
58,216
+34.86%
|
$0
$0.79 P/Share
|
|
Mar 22
2023
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
41,784
-24.65%
|
$668,544
$16.46 P/Share
|
|
Mar 22
2023
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
41,784
+17.95%
|
$0
$0.79 P/Share
|
|
Mar 20
2023
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Open market or private sale
|
Direct |
50,000
-26.59%
|
$800,000
$16.07 P/Share
|
|
Mar 20
2023
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+21.0%
|
$50,000
$1.13 P/Share
|
|
Feb 15
2023
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,435
-5.97%
|
-
|
|
Feb 15
2023
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+19.68%
|
-
|
|
Feb 15
2023
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+3.92%
|
-
|
|
Feb 15
2023
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,125
-29.3%
|
-
|
|
Feb 15
2023
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,666
+50.0%
|
-
|
|
Feb 15
2023
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+1.26%
|
-
|
|
Feb 15
2023
|
Philip H Coelho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+2.52%
|
-
|
|
Feb 15
2023
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+1.19%
|
-
|
|
Feb 15
2023
|
Patrick J Mcenany Director |
SELL
Payment of exercise price or tax liability
|
Direct |
14,204
-0.36%
|
-
|